Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02160145 |
|---|---|
| Brief Title: | Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease |
| First Submitted : | June 6, 2014 |
| First Submitted that Met QC Criteria : | June 6, 2014 |
| First Posted : | June 10, 2014 (Estimate) |
| Results First Submitted : | May 1, 2018 |
| Results First Submitted that Met QC Criteria : | July 13, 2018 |
| Results First Posted : | August 8, 2018 |
| Certification/Extension First Submitted : | September 18, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | September 18, 2017 |
| Certification/Extension First Posted : | September 26, 2017 |
| Last Update Submitted that Met QC Criteria : | July 13, 2018 |
| Last Update Posted : | August 8, 2018 |